Safety and Immunogenicity of the Sing2016 M2SR H3N2 Monovalent Influenza Vaccine in Adults Ages 50 to 85 Years Old
Clinical trial NCT04785794 · COMPLETED
Trial details
- NCT number
- NCT04785794
- Sponsor
- FluGen Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-30
- Primary completion
- 2021-11-30
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.